Bioserve Biotechnologies (India) Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.66 Cr
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.08 Cr
- Revenue Growth 26.62%
- Profit Growth 34.77%
- Ebitda 47.79%
- Net Worth -26.15%
- Total Assets -24.72%
About Bioserve Biotechnologies (India)
Bioserve Biotechnologies (India) Private Limited (BBIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 February 1994 and has a history of 30 years and 11 months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.66 Cr.
The company has closed loans amounting to ₹1.08 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Daisuke Usui, Venkateswarlu Prathipati, and Chikafumi Yokoyama serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U72200TG1994PTC017063
-
Company No.
017063
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Feb 1994
-
Date of AGM
25 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Bioserve Biotechnologies (India) Private Limited offer?
Bioserve Biotechnologies (India) Private Limited offers a wide range of products and services, including Product Development Research, Custom Synthesis Service.
Who are the key members and board of directors at Bioserve Biotechnologies (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Daisuke Usui
|
Director | 16-Dec-2020 | Current |
|
Chikafumi Yokoyama
|
Director | 07-Oct-2020 | Current |
Venkateswarlu Prathipati
|
Director | 23-Feb-2017 | Current |
Financial Performance of Bioserve Biotechnologies (India).
Bioserve Biotechnologies (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.62% increase. The company also saw a substantial improvement in profitability, with a 34.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 26.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioserve Biotechnologies (India)?
In 2023, Bioserve Biotechnologies (India) had a promoter holding of 99.56% and a public holding of 0.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹1.08 Cr
Charges Breakdown by Lending Institutions
- Jain Sons Finlease Limited : 0.75 Cr
- State Bank Of Hyderabad : 0.25 Cr
- Ventureast Trustee Company Private Limited : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Dec 2012 | Jain Sons Finlease Limited | ₹7.50 M | Satisfied |
| 31 Dec 2007 | Ventureast Trustee Company Private Limited | ₹0.75 M | Satisfied |
| 26 Dec 2002 | State Bank Of Hyderabad | ₹2.50 M | Satisfied |
How Many Employees Work at Bioserve Biotechnologies (India)?
Bioserve Biotechnologies (India) has a workforce of 28 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioserve Biotechnologies (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioserve Biotechnologies (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
